These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 24717409)

  • 1. Nanoparticle-mediated pulmonary drug delivery: a review.
    Paranjpe M; Müller-Goymann CC
    Int J Mol Sci; 2014 Apr; 15(4):5852-73. PubMed ID: 24717409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine in pulmonary delivery.
    Mansour HM; Rhee YS; Wu X
    Int J Nanomedicine; 2009; 4():299-319. PubMed ID: 20054434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary delivery of anti-inflammatory agents.
    Ali ME; McConville JT; Lamprecht A
    Expert Opin Drug Deliv; 2015 Jun; 12(6):929-45. PubMed ID: 25534260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles.
    Date AA; Joshi MD; Patravale VB
    Adv Drug Deliv Rev; 2007 Jul; 59(6):505-21. PubMed ID: 17574295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of SARS-CoV2 that may be useful for nanoparticle pulmonary drug delivery.
    Rabiei M; Kashanian S; Samavati SS; Derakhshankhah H; Jamasb S; McInnes SJP
    J Drug Target; 2022 Mar; 30(3):233-243. PubMed ID: 34415800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates.
    Abdelaziz HM; Gaber M; Abd-Elwakil MM; Mabrouk MT; Elgohary MM; Kamel NM; Kabary DM; Freag MS; Samaha MW; Mortada SM; Elkhodairy KA; Fang JY; Elzoghby AO
    J Control Release; 2018 Jan; 269():374-392. PubMed ID: 29180168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled lipid nanocarriers for pulmonary delivery of glucocorticoids: Previous strategies, recent advances and key factors description.
    Altube MJ; Perez N; Romero EL; Morilla MJ; Higa LH; Perez AP
    Int J Pharm; 2023 Jul; 642():123146. PubMed ID: 37330156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colloidal systems for tumor targeting.
    Storm G; Crommelin DJ
    Hybridoma; 1997 Feb; 16(1):119-25. PubMed ID: 9085138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery of nanoparticles for the treatment of lung diseases.
    Azarmi S; Roa WH; Löbenberg R
    Adv Drug Deliv Rev; 2008 May; 60(8):863-75. PubMed ID: 18308418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-based pulmonary delivery system: a review and future considerations of formulation strategies and limitations.
    Ngan CL; Asmawi AA
    Drug Deliv Transl Res; 2018 Oct; 8(5):1527-1544. PubMed ID: 29881970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanocarrier-Mediated Drug Delivery via Inhalational Route for Lung Cancer Therapy: A Systematic and Updated Review.
    Ara N; Hafeez A
    AAPS PharmSciTech; 2024 Feb; 25(3):47. PubMed ID: 38424367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-based carriers: manufacturing and applications for pulmonary route.
    Jaafar-Maalej C; Elaissari A; Fessi H
    Expert Opin Drug Deliv; 2012 Sep; 9(9):1111-27. PubMed ID: 22724618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonviral pulmonary delivery of siRNA.
    Merkel OM; Kissel T
    Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art.
    Weber S; Zimmer A; Pardeike J
    Eur J Pharm Biopharm; 2014 Jan; 86(1):7-22. PubMed ID: 24007657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery.
    Willis L; Hayes D; Mansour HM
    Lung; 2012 Jun; 190(3):251-62. PubMed ID: 22274758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in noninvasive pulmonary gene therapy.
    Densmore CL
    Curr Drug Deliv; 2006 Jan; 3(1):55-63. PubMed ID: 16472094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assembling nanoparticle coatings to improve the drug delivery performance of lipid based colloids.
    Simovic S; Barnes TJ; Tan A; Prestidge CA
    Nanoscale; 2012 Feb; 4(4):1220-30. PubMed ID: 22159191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colloidal drug carriers: achievements and perspectives.
    Barratt G
    Cell Mol Life Sci; 2003 Jan; 60(1):21-37. PubMed ID: 12613656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhalable liposomes for treating lung diseases: clinical development and challenges.
    Ponkshe P; Feng S; Tan C
    Biomed Mater; 2021 Jul; 16(5):. PubMed ID: 34134097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.